Publications

Found 3 results
Filters: Author is A.B. Oliveira  [Clear All Filters]
2011
W. F. Costa, Oliveira, A. B., and Nepomuceno, J. C., Lapachol as an epithelial tumor inhibitor agent in Drosophila melanogaster heterozygote for tumor suppressor gene wts, vol. 10, pp. 3236-3245, 2011.
Balassiano IT, De Paulo SA, Henriques SN, Cabral MC, et al. (2005). Demonstration of the lapachol as a potential drug for reducing cancer metastasis. Oncol. Rep. 13: 329-333. PMid:15643520 Bolton JL, Trush MA, Penning TM, Dryhurst G, et al. (2000). Role of quinones in toxicology. Chem. Res. Toxicol. 13: 135-160. http://dx.doi.org/10.1021/tx9902082 PMid:10725110 Boveris A, Docampo R, Turrens JF and Stoppani AO (1978). Effect of beta-lapachone on superoxide anion and hydrogen peroxide production in Trypanosoma cruzi. Biochem. J. 175: 431-439. PMid:217340    PMCid:1186088 Carvalho LH, Rocha EM, Raslan DS, Oliveira AB, et al. (1988). In vitro activity of natural and synthetic naphthoquinones against erythrocytic stages of Plasmodium falciparum. Braz. J. Med. Biol. Res. 21: 485-487. PMid:3067810 Castellanos JRG, Prieto JM and Heinrich M (2009). Red Lapacho (Tabebuia impetiginosa) - a global ethnopharmacological commodity? J. Ethnopharmacol. 121: 1-13. http://dx.doi.org/10.1016/j.jep.2008.10.004 PMid:18992801 de Witte NV, Stoppani AO and Dubin M (2004). 2-Phenyl-beta-lapachone can affect mitochondrial function by redox cycling mediated oxidation. Arch. Biochem. Biophys. 432: 129-135. http://dx.doi.org/10.1016/j.abb.2004.09.020 PMid:15542051 Edgar BA and Lehner CF (1996). Developmental control of cell cycle regulators: a fly’s perspective. Science 274: 1646- 1652. http://dx.doi.org/10.1126/science.274.5293.1646 PMid:8939845 Eeken JC, Klink I, van Veen BL, Pastink A, et al. (2002). Induction of epithelial tumors in Drosophila melanogaster heterozygous for the tumor suppressor gene wts. Environ. Mol. Mutagen. 40: 277-282. http://dx.doi.org/10.1002/em.10119 PMid:12489118 Esteves-Souza A, Figueiredo DV, Esteves A, Camara CA, et al. (2007). Cytotoxic and DNA-topoisomerase effects of lapachol amine derivatives and interactions with DNA. Braz. J. Med. Biol. Res. 40: 1399-1402. http://dx.doi.org/10.1590/S0100-879X2006005000159 PMid:17713652 Falkenberg MB (2003). Quinonas. In: Farmacognosia da Planta ao Medicamento (Simões CMO, Schenkel EP, Gosmann G, Mello JCP, et al., eds.). 5ª ed. UFRGS, Florianópolis. 25: 657-683. Grazziotin JD, Schapoval EE, Chaves CG, Gleye J, et al. (1992). Phytochemical and analgesic investigation of Tabebuia chrysotricha. J. Ethnopharmacol. 36: 249-251. http://dx.doi.org/10.1016/0378-8741(92)90051-R Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, et al. (2005). The Pharmacological Basis of Therapeutics. 9th edn. McGraw-Hill, New York. Hussain H, Krohn K, Ahmad VU, Miana GA, et al. (2007). Lapachol: an overview. Arkivoc ii: 145-171. Justice RW, Zilian O, Woods DF, Noll M, et al. (1995). The Drosophila tumor suppressor gene warts encodes a homolog of human myotonic dystrophy kinase and is required for the control of cell shape and proliferation. Genes Dev. 9: 534-546. http://dx.doi.org/10.1101/gad.9.5.534 Kinghorn AD, Farnsworth NR, Soejarto DD, Cordell GA, et al. (2003). Novel strategies for the discovery of plant-derived anticancer agents. Pharm. Biol. 41: 53-67. http://dx.doi.org/10.1080/1388020039051744 Knudson AG (1993). Antioncogenes and human cancer. Proc. Natl. Acad. Sci. U. S. A. 90: 10914-10921. http://dx.doi.org/10.1073/pnas.90.23.10914 Krishnan P and Bastow KF (2000). Novel mechanisms of DNA topoisomerase II inhibition by pyranonaphthoquinone derivatives-eleutherin, alpha lapachone, and beta lapachone. Biochem. Pharmacol. 60: 1367-1379. http://dx.doi.org/10.1016/S0006-2952(00)00437-8 Kumagai Y, Tsurutani Y, Shinyashiki M, Homma-Takeda S, et al. (1997). Bioactivation of lapachol responsible for DNA scission by NADPH-cytochrome P450 reductase. Environ. Toxicol. Pharmacol. 3: 245-250. http://dx.doi.org/10.1016/S1382-6689(97)00019-7 Lima NM, dos Santos AF, Porfirio Z, Goulart MO, et al. (2002). Toxicity of lapachol and isolapachol and their potassium salts against Biomphalaria glabrata, Schistosoma mansoni cercariae, Artemia salina and Tilapia nilotica. Acta Trop. 83: 43-47. http://dx.doi.org/10.1016/S0001-706X(02)00055-4 Lima NM, Correia CS, Leon LL, Machado GM, et al. (2004). Antileishmanial activity of lapachol analogues. Mem. Inst. Oswaldo Cruz 99: 757-761. http://dx.doi.org/10.1590/S0074-02762004000700017 Maeda M, Murakami M, Takegami T and Ota T (2008). Promotion or suppression of experimental metastasis of B16 melanoma cells after oral administration of lapachol. Toxicol. Appl. Pharmacol. 229: 232-238. http://dx.doi.org/10.1016/j.taap.2008.01.008 PMid:18294668 Netto Chaquip D, da Silva AJ, Salustiano EJ, Bacelar TS, et al. (2010). New pterocarpanquinones: synthesis, antineoplasic activity on cultured human malignant cell lines and TNF-alpha modulation in human PBMC cells. Bioorg. Med. Chem. 18: 1610-1616. http://dx.doi.org/10.1016/j.bmc.2009.12.073 Newman DJ, Cragg GM and Snader KM (2003). Natural products as sources of new drugs over the period 1981-2002. J. Nat. Prod. 66: 1022-1037. http://dx.doi.org/10.1021/np030096l PMid:12880330 O’Brien PJ (1991). Molecular mechanisms of quinone cytotoxicity. Chem. Biol. Interact. 80: 1-41. http://dx.doi.org/10.1016/0009-2797(91)90029-7 Oliveira MF (2000). Contribuição ao Conhecimento Químico das Espécies Tabebuia serratifolia Nichols e Tabebuia rosa Bertol. Doctoral thesis, Curso de Pós-Graduação em Química Orgânica. Universidade Federal do Ceará, Fortaleza. Ravelo AG, Estevez-Braun A, Chavez-Orellana H, Perez-Sacau E, et al. (2004). Recent studies on natural products as anticancer agents. Curr. Top. Med. Chem. 4: 241-265. http://dx.doi.org/10.2174/1568026043451500 Rodrigues AM, de Paula JE, Roblot F, Fournet A, et al. (2005). Larvicidal activity of Cybistax antisyphilitica against Aedes aegypti larvae. Fitoterapia 76: 755-757. http://dx.doi.org/10.1016/j.fitote.2005.08.015 PMid:16229968 Santos AF, Ferraz PA, de Abreu FC, Chiari E, et al. (2001). Molluscicidal and trypanocidal activities of lapachol derivatives. Planta Med. 67: 92-93. http://dx.doi.org/10.1055/s-2001-10877 Schmandt R and Mills GB (1993). Genomic components of carcinogenesis. Clin. Chem. 39: 2375-2385. PMid:8222249 Sidorov RA, Ugnivenko EG, Khovanova EM and Belitsky GA (2001). Induction of tumor clones in D. melanogaster wts/+ heterozygotes with chemical carcinogens. Mutat. Res. 498: 181-191. PMid:11673083 Silva AJM, Netto Chaquip D, Lima WP, Torres-Santos EC, et al. (2009). Antitumoral, antileishmanial and antimalarial activity of pentacyclic 1,4-naphthoquinone derivatives. J. Braz. Chem. Soc. 20: 176-182. http://dx.doi.org/10.1590/S0103-50532009000100026 Silva MN, Ferreira VF and Souza MCBV (2003). An overview of the chemistry and pharmacology of naphthoquinone with emphasis on B-lapachone and derivatives. Quim. Nova 26: 407-416. http://dx.doi.org/10.1590/S0100-40422003000300019 Suffness M and Douros J (1980). Miscellaneous Natural Products with Antitumor Activity. In: Anticancer Agents Based on Natural Product Models (JM Cassady and JD Douros, eds.). Academic Press, New York, 465-487. Wang JC (1996). DNA topoisomerases. Annu. Rev. Biochem. 65: 635-692. http://dx.doi.org/10.1146/annurev.bi.65.070196.003223 PMid:8811192